Novo Nordisk’s Wegovy weight loss drug launches in the Uk

Novo Nordisk’s Wegovy weight loss drug launches in the Uk


Offers of the weight-loss drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy.

Stefan Trumpf | Photo Alliance | Getty Photographs

Novo Nordisk introduced its Wegovy pounds decline injection in the U.K. on Monday, advancing the drug’s rollout in Europe regardless of ongoing source constraints.

The Danish pharmaceutical giant stated that the weekly injection would be available in the beginning “through a controlled and constrained launch,” with only certain patients suitable to acquire the drug on the country’s National Overall health Services.

To qualify for procedure, sufferers ought to be on the NHS’s fat administration company, have at the very least 1 pounds-relevant affliction and have a human body mass index of 35, according to suggestions outlined by the Nationwide Institute for Care and Excellence.

The drug will also be out there privately via a “registered healthcare experienced,” Novo Nordisk stated in a assertion, without introducing even further detail.

The corporation did not react to a CNBC request for comment above the cost of the drug.

In the U.S., Wegovy has a record selling price of $1,350 for a every month dose, whilst in Europe it retails for all around 170 to 300 euros ($190-$330) per month.

British insurance policy business Aviva, which offers private health insurance plan to around 1.1 million Brits, on Monday reported that Wegovy would not be covered under its policy, in accordance to Reuters.

‘Closely monitoring’ provide troubles

Wegovy’s U.K. expansion comes just in excess of a month soon after the drug introduced in Germany — its third European marketplace at the time, soon after Denmark and Norway.

Surging demand for the body weight decline drug, as perfectly as a sequence of clinical research which stage to its broader overall health positive aspects, have shot the firm’s shares to record highs. On Friday, it briefly unseated French luxurious goods behemoth LVMH to develop into Europe’s most precious firm.

'Miracle' drugs could remake the weight loss industry

Supply constraints proceed to weigh large on the drug’s rollout, with CEO Lars Fruergaard Jorgensen telling a Reuters Newsmakers occasion very last thirty day period that it could be “some a long time” ahead of the company can satisfy all shoppers.

In the U.K., Novo Nordisk claimed that “a proportion” of out there offer would be allocated particularly for NHS cure, and that the organization would operate with healthcare skilled to ensure that “clients with the optimum unmet clinical will need” are prioritized.

“We are intently checking Wegovy demand and are operating with regulators and providers to make sure people dwelling with being overweight can have entry to and stay on treatment,” it included.

The organization has also limited provisions in other markets. In Could, it minimize the U.S. supply of starter doses to ensure continuity for current sufferers, though in Germany it advised health professionals to “prescribe responsibly,” limiting prescriptions to clients with medical demands.



Resource

UK put on a war footing with defense overhaul — but is it too little, too late?
World

UK put on a war footing with defense overhaul — but is it too little, too late?

Britain’s Prime Minister Keir Starmer (C), Britain’s Defence Secretary John Healey (2nd R) and managing director of BAE Systems’ naval ships business Simon Lister (R) visit the BAE Systems’Govan facility, in Glasgow, on June 2, 2025. Britain announced it will build 12 new attack submarines as it unveiled a major defense review to deal with […]

Read More
European autos stocks fall 2% as Trump’s 50% steel tariffs inflate EU trade tensions
World

European autos stocks fall 2% as Trump’s 50% steel tariffs inflate EU trade tensions

Mid-morning market moves The mood in equities remains downbeat in Europe, with the regional Stoxx 600 index 0.25% lower at 10:30 a.m. U.K. time as investors eye the potential for escalating U.S.-EU tariffs. Autos stocks on the index are down 1.75%, technology stocks are down 1.2% and household goods are down 1%. Oil and gas […]

Read More
As the TACO trade goes viral, another is gaining traction: ‘Anywhere But The USA’
World

As the TACO trade goes viral, another is gaining traction: ‘Anywhere But The USA’

“It’s become quite emotive,” one market watcher told CNBC. “Nobody wants to invest in an environment where the government might change its mind overnight.” Source

Read More